Clinicians, Scientists Apply Symptom Tracking to Outpatient Care Using Famotidine: Northwell Health
June 05, 2020
June 05, 2020
COLD SPRING HARBOR, New York, June 5 -- Northwell Health issued the following news:
A patient-reported symptom tracking method used for patients with cancer has now been adapted for patients with the novel coronavirus. Investigating the effect of famotidine on non-hospitalized patients with COVID-19, clinicians at Northwell Health (https://www.northwell.edu/about/news) and cancer researchers at Cold Spring Harbor Laboratory (https://www.cshl.edu/) (CSHL) developed the method to use . . .
A patient-reported symptom tracking method used for patients with cancer has now been adapted for patients with the novel coronavirus. Investigating the effect of famotidine on non-hospitalized patients with COVID-19, clinicians at Northwell Health (https://www.northwell.edu/about/news) and cancer researchers at Cold Spring Harbor Laboratory (https://www.cshl.edu/) (CSHL) developed the method to use . . .